SAN DIEGO, May 24, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the following investor conferences: -- Deutsche Bank Securities 38(th) Annual ...
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) opened trading at 5.34, 0.10 below its previous close of 5.44. Since the slow start THLD has rallied and is currently up 1.65% on volume of 158.36K - average volume is 597.61K.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a biopharmaceutical company that engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system ...
Bullish bets were unusually popular on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) yesterday, with call volume on the drug stock rising to more than three times the expected level.
Editor's Note: Related tickers: Exxon Mobil Corporation (NYSE:XOM), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), 3M Co (NYSE:MMM), Akamai Technologies, Inc. (NASDAQ:AKAM), QUALCOMM, Inc. (NASDAQ:QCOM), VIVUS, Inc. (NASDAQ:VVUS), ...
Investors Alert: Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Mechel OAO, Michael Kors Holdings Ltd, DeVry Inc. (NYSE:DV) (SBWire) ThePennyStockProfiler, an investment community with a special focus on updating investors with recent news on the U.S.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A sharp drop in Arena Pharmaceuticals (NASDAQ:ARNA) followed after the company reported quarterly earnings and a withdrawal of its Marketing Authorization Application (�MAA�) in the EU.
SAN DIEGO, May 10, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, ...
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.